BLACKROCK ADVISORS LLC - RAPTOR PHARMACEUTICAL CORP ownership

Quarter-by-quarter ownership
BLACKROCK ADVISORS LLC ownership history of RAPTOR PHARMACEUTICAL CORP
ValueSharesWeighting
Q3 2016$1,279,000
-12.4%
142,544
-47.6%
0.00%0.0%
Q2 2016$1,460,000
+17.5%
271,894
+0.6%
0.00%0.0%
Q1 2016$1,243,000
-17.2%
270,196
-6.4%
0.00%
-50.0%
Q4 2015$1,502,000
-18.9%
288,758
-5.7%
0.00%0.0%
Q3 2015$1,853,000
-47.9%
306,262
+36.0%
0.00%
-50.0%
Q2 2015$3,556,000
+301.8%
225,230
+176.6%
0.00%
+300.0%
Q1 2015$885,000
+137.9%
81,430
+130.0%
0.00%
Q4 2014$372,000
+5.4%
35,403
-3.9%
0.00%
Q3 2014$353,000
-22.9%
36,822
-7.2%
0.00%
Q2 2014$458,000
+3.2%
39,695
-10.6%
0.00%
Q1 2014$444,000
-14.3%
44,402
+11.5%
0.00%
Q4 2013$518,000
-5.0%
39,811
+8.9%
0.00%
-100.0%
Q3 2013$545,000
+70.8%
36,551
+7.2%
0.00%
Q2 2013$319,00034,0900.00%
Other shareholders

There were no reported owners of RAPTOR PHARMACEUTICAL CORP in Q4 2016.

NameSharesValueWeighting ↓
View complete list of RAPTOR PHARMACEUTICAL CORP shareholders